Literature DB >> 25937022

Stigma and discrimination related to mental illness in low- and middle-income countries.

M Semrau1, S Evans-Lacko1, M Koschorke1, L Ashenafi1, G Thornicroft1.   

Abstract

AIMS: This paper aims to provide an overview of evidence from low- and middle-income countries (LAMICs) worldwide to address: the nature of stigma and discrimination, relevant context-specific factors, global patterns of these phenomena and their measurement and quantitative and qualitative evidence of interventions intended to reduce their occurrence and impact. The background to this study is that the large majority of studies concerned with identifying effective interventions to reduce stigma and discrimination originate in high-income countries (HICs). This paper therefore presents such evidence from, and relevant to, LAMICs.
METHODS: Conceptual overview of the relevant peer-reviewed and grey literature on stigma and discrimination related to mental illness in LAMICs are available in English, Spanish, French and Russian.
RESULTS: Few intervention studies were identified related to stigma re-education in LAMICs. None of these addressed behaviour change/discrimination, and there were no long-term follow-up studies. There is therefore insufficient evidence at present to know which overall types of intervention may be effective and feasible and in LAMICs, how best to target key groups such as healthcare staff, and how far they may need to be locally customised to be acceptable for large-scale use in these settings. In particular, forms of social contacts, which have been shown to be the most effective intervention to reduce stigma among adults in HICs, have not yet been assessed sufficiently to know whether these methods are also effective in LAMICs.
CONCLUSION: Generating information about effective interventions to reduce stigma and discrimination in LAMICs is now an important mental health priority worldwide.

Entities:  

Keywords:  Discrimination; evidence-based psychiatry; health service research; mental illness stigma

Year:  2015        PMID: 25937022     DOI: 10.1017/S2045796015000359

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  53 in total

1.  Determinants of treatment of mental disorders in Lebanon: barriers to treatment and changing patterns of service use.

Authors:  E G Karam; G E Karam; C Farhat; L Itani; J Fayyad; A N Karam; Z Mneimneh; R Kessler; G Thornicroft
Journal:  Epidemiol Psychiatr Sci       Date:  2018-08-13       Impact factor: 6.892

2.  Viewpoint: WHO World Mental Health Surveys International College Student initiative: Implementation issues in low- and middle-income countries.

Authors:  Sara Evans-Lacko; Graham Thornicroft
Journal:  Int J Methods Psychiatr Res       Date:  2019-01-06       Impact factor: 4.035

Review 3.  Challenges and Opportunities in Global Mental Health: a Research-to-Practice Perspective.

Authors:  Milton L Wainberg; Pamela Scorza; James M Shultz; Liat Helpman; Jennifer J Mootz; Karen A Johnson; Yuval Neria; Jean-Marie E Bradford; Maria A Oquendo; Melissa R Arbuckle
Journal:  Curr Psychiatry Rep       Date:  2017-05       Impact factor: 5.285

4.  The Role of Insight in Moderating the Association Between Depressive Symptoms in People With Schizophrenia and Stigma Among Their Nearest Relatives: A Pilot Study.

Authors:  Dzmitry Krupchanka; Mikhail Katliar
Journal:  Schizophr Bull       Date:  2016-03-12       Impact factor: 9.306

Review 5.  Psychological Treatments for the World: Lessons from Low- and Middle-Income Countries.

Authors:  Daisy R Singla; Brandon A Kohrt; Laura K Murray; Arpita Anand; Bruce F Chorpita; Vikram Patel
Journal:  Annu Rev Clin Psychol       Date:  2017-05-08       Impact factor: 18.561

6.  A Mixed-Methods Study: Sex Differences in Experiences of Stigma Associated With Alcoholism and Alcohol Use Disorders Among Injury Patients in Tanzania.

Authors:  S Michelle Griffin; Francis P Karia; Armand Zimmerman; Mary Catherine C Minnig; Monica Swahn; Jennifer Makelarski; Blandina T Mmbaga; João Ricardo Nickenig Vissoci; Catherine A Staton
Journal:  Alcohol Clin Exp Res       Date:  2020-08-09       Impact factor: 3.455

7.  The cross-national epidemiology of specific phobia in the World Mental Health Surveys.

Authors:  K J Wardenaar; C C W Lim; A O Al-Hamzawi; J Alonso; L H Andrade; C Benjet; B Bunting; G de Girolamo; K Demyttenaere; S E Florescu; O Gureje; T Hisateru; C Hu; Y Huang; E Karam; A Kiejna; J P Lepine; F Navarro-Mateu; M Oakley Browne; M Piazza; J Posada-Villa; M L Ten Have; Y Torres; M Xavier; Z Zarkov; R C Kessler; K M Scott; P de Jonge
Journal:  Psychol Med       Date:  2017-02-22       Impact factor: 7.723

8.  Experience of stigma in the public life of relatives of people diagnosed with schizophrenia in the Republic of Belarus.

Authors:  Dzmitry Krupchanka; Nina Kruk; Norman Sartorius; Silvia Davey; Petr Winkler; Joanna Murray
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-03-01       Impact factor: 4.328

9.  The association between psychotic experiences and health-related quality of life: a cross-national analysis based on World Mental Health Surveys.

Authors:  Jordi Alonso; Sukanta Saha; Carmen C W Lim; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Corina Benjet; Evelyn J Bromet; Louisa Degenhardt; Giovanni de Girolamo; Oluyomi Esan; Silvia Florescu; Oye Gureje; Josep M Haro; Chiyi Hu; Elie G Karam; Georges Karam; Viviane Kovess-Masfety; Jean-Pierre Lepine; Sing Lee; Zeina Mneimneh; Fernando Navarro-Mateu; Jose Posada-Villa; Nancy A Sampson; Kate M Scott; Juan Carlos Stagnaro; Margreet Ten Have; Maria Carmen Viana; Ronald C Kessler; John J McGrath
Journal:  Schizophr Res       Date:  2018-05-16       Impact factor: 4.939

10.  The association between social support through contacts with Accredited Social Health Activists (ASHAs) and antenatal anxiety among women in Mysore, India: a cross-sectional study.

Authors:  Nivedita L Bhushan; Karl Krupp; Poornima Jaykrishna; Kavitha Ravi; Anisa Khan; Rahul Shidhaye; Sandra Kiplagat; Vijaya Srinivas; Purnima Madhivanan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-03-07       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.